NCT02006030View on ClinicalTrials.gov

Ph 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Vs TACE Alone in Patients With Unresectable Hepatocellular Carcinoma

PHASE2CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

October 15, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

November 1, 2017

Conditions

Unresectable Hepatocellular Carcinoma

Interventions

DRUG

ADI-PEG 20

DRUG

Transarterial chemoembolization

Trial Locations (4)

Unknown

CMUH, Taichung

National Taiwan University Hospital, Taipei

TP-VGH, Taipei

CGMH-LK, Taoyuan District

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Polaris Group

INDUSTRY